RPG Life Sciences Limited (RPGLIFE) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.020x

Based on the latest financial reports, RPG Life Sciences Limited (RPGLIFE) has a cash flow conversion efficiency ratio of 0.020x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs112.70 Million ≈ $1.22 Million USD) by net assets (Rs5.54 Billion ≈ $59.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

RPG Life Sciences Limited - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how RPG Life Sciences Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read RPG Life Sciences Limited debt and liabilities for a breakdown of total debt and financial obligations.

RPG Life Sciences Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of RPG Life Sciences Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Priority Technology Holdings Inc
NASDAQ:PRTH
-0.399x
Guangdong Anjubao Digital Tech
SHE:300155
0.000x
Fastned B.V.
AS:FAST
-0.057x
Ophir High Conviction Fund
AU:OPH
-0.029x
Gladstone Land Corporation
NASDAQ:LAND
0.016x
Jiangsu Wanlin Modern Logistic
SHG:603117
0.017x
Taiwan Mask Corp
TW:2338
0.116x
Luxfer Holdings PLC
NYSE:LXFR
0.052x

Annual Cash Flow Conversion Efficiency for RPG Life Sciences Limited (2005–2025)

The table below shows the annual cash flow conversion efficiency of RPG Life Sciences Limited from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see RPGLIFE market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs5.31 Billion
≈ $57.37 Million
Rs778.60 Million
≈ $8.42 Million
0.147x -41.70%
2024-03-31 Rs3.75 Billion
≈ $40.54 Million
Rs943.60 Million
≈ $10.20 Million
0.252x -14.74%
2023-03-31 Rs3.08 Billion
≈ $33.27 Million
Rs908.20 Million
≈ $9.82 Million
0.295x +16.63%
2022-03-31 Rs2.56 Billion
≈ $27.66 Million
Rs647.50 Million
≈ $7.00 Million
0.253x -5.96%
2021-03-31 Rs2.16 Billion
≈ $23.41 Million
Rs582.70 Million
≈ $6.30 Million
0.269x -5.25%
2020-03-31 Rs1.77 Billion
≈ $19.10 Million
Rs501.70 Million
≈ $5.43 Million
0.284x -0.38%
2019-03-31 Rs1.60 Billion
≈ $17.36 Million
Rs457.80 Million
≈ $4.95 Million
0.285x +200.68%
2018-03-31 Rs1.55 Billion
≈ $16.74 Million
Rs146.80 Million
≈ $1.59 Million
0.095x +93.85%
2017-03-31 Rs1.54 Billion
≈ $16.66 Million
Rs75.40 Million
≈ $815.42K
0.049x -80.08%
2016-03-31 Rs1.34 Billion
≈ $14.45 Million
Rs328.10 Million
≈ $3.55 Million
0.246x +1660.38%
2015-03-31 Rs1.25 Billion
≈ $13.54 Million
Rs-19.70 Million
≈ $-213.05K
-0.016x +64.40%
2014-03-31 Rs1.26 Billion
≈ $13.60 Million
Rs-55.60 Million
≈ $-601.29K
-0.044x -127.36%
2013-03-31 Rs762.30 Million
≈ $8.24 Million
Rs123.20 Million
≈ $1.33 Million
0.162x -23.92%
2012-03-31 Rs741.40 Million
≈ $8.02 Million
Rs157.50 Million
≈ $1.70 Million
0.212x +10.23%
2011-03-31 Rs748.31 Million
≈ $8.09 Million
Rs144.21 Million
≈ $1.56 Million
0.193x -39.62%
2010-03-31 Rs644.31 Million
≈ $6.97 Million
Rs205.66 Million
≈ $2.22 Million
0.319x -39.17%
2009-03-31 Rs549.21 Million
≈ $5.94 Million
Rs288.19 Million
≈ $3.12 Million
0.525x -4.46%
2008-03-31 Rs492.02 Million
≈ $5.32 Million
Rs270.23 Million
≈ $2.92 Million
0.549x +166.15%
2007-03-31 Rs742.36 Million
≈ $8.03 Million
Rs153.19 Million
≈ $1.66 Million
0.206x +67.70%
2006-03-31 Rs667.72 Million
≈ $7.22 Million
Rs82.17 Million
≈ $888.59K
0.123x -71.98%
2005-03-31 Rs150.60 Million
≈ $1.63 Million
Rs66.13 Million
≈ $715.16K
0.439x --

About RPG Life Sciences Limited

NSE:RPGLIFE India Drug Manufacturers - Specialty & Generic
Market Cap
$410.49 Million
Rs37.96 Billion INR
Market Cap Rank
#13558 Global
#642 in India
Share Price
Rs2295.00
Change (1 day)
+13.03%
52-Week Range
Rs1744.00 - Rs2657.80
All Time High
Rs2828.55
About

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. … Read more